Drug Development

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Articles

Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.

Gauging Biopharm Outsourcing

A complete and unedited audio slideshow of the Excipient Fest roundtable on atypical visible particles

Excipient Fest Slideshow and Audio

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Flow chemistry and microreactors offer an alternative to traditional batch manufacturing.

What is Ahead in Chemical API Manufacturing

Companies roll out expansions in manufacturing high-potency APIs and finished products.

High-Potency Manufacturing Remains Strong

Flow chemistry and microreactors offer alternatives to traditional batch manufacturing.

35th Anniversary Special: What's Ahead in Chemical API Manufacturing

Industry experts share perspectives on analytical instrumentation, methods, and data analysis.

35th Anniversary Special: The Today and Tomorrow of Process Analytical Technology

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the June 2012 edition from EMD Millipore and Meissner Filtration Products.

June 2012 Editor's Picks: Products from EMD Millipore and Meissner Filtration Products

Peptides and related technologies to are starting to improve production.

Peptides Gain Traction in Drug Development

Amy Ritter was Scientific Editor, BioPharm International.

Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.

Looking for Fingerprints: Bioanalytical Characterization of Biosimilars

Industry wants more innovation, but can suppliers meet customer needs?

APIs and Excipients